In Vivo Effects of Bradykinin B2 Receptor Agonists with Varying Susceptibility to Peptidases

Frontiers in Pharmacology
Mélissa JeanH Bachelard

Abstract

We reported evidence of bradykinin (BK) regeneration from C-terminal extended BK sequences that behave as peptidase-activated B2 receptor (B2R) agonists. Further to these in vitro studies, we carried out in vivo experiments to verify hemodynamic effects of BK analogs exhibiting variable susceptibility toward vascular and blood plasma peptidases. Rats were anesthetized and instrumented to record blood pressure and heart rate responses to bolus intravenous (i.v.) injection of increasing doses of BK, B-9972 (D-Arg-[Hyp(3),Igl(5),Oic(7),Igl(8)]-BK), BK-Arg, BK-His-Leu or BK-Ala-Pro, in the absence or presence of specific inhibitors. In some experiments, pulsed Doppler flow probes measured hindquarter Doppler shift in response to i.v. injections of kinins. BK caused rapid, transient and dose-related hypotensive effects. These effects were potentiated ∼15-fold by the angiotensin converting enzyme (ACE) inhibitor, enalaprilat, but extensively inhibited by icatibant (a B2R antagonist) and not influenced by the Arg-carboxypeptidase (CP) inhibitor (Plummer's inhibitor). The hypotensive responses elicited by the peptidase-resistant B2R agonist, B-9972, were not affected by enalaprilat, but were inhibited by icatibant. The hypotensive resp...Continue Reading

References

Jul 9, 1979·Life Sciences·A Nasjletti, K U Malik
Mar 1, 1991·British Journal of Pharmacology·F J HockJ Knolle
Mar 1, 1991·British Journal of Pharmacology·K WirthJ Knolle
Jan 30, 1981·Biochemical and Biophysical Research Communications·T H Plummer, T J Ryan
Oct 29, 2000·British Journal of Pharmacology·J F LarrivéeF Marceau
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·P MenetonF Alhenc-Gelas
Jun 19, 2001·American Journal of Physiology. Heart and Circulatory Physiology·M CyrA Adam
Dec 31, 2002·European Journal of Pharmacology·Paul ScottJenny Longmore
Feb 15, 2003·European Journal of Pharmacology·Yuko MutoHidemi Ishii
Apr 30, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·V Griol-CharhbiliC Richer
Sep 24, 2005·Journal of Pharmacological Sciences·Marie Eve MoreauAlbert Adam
Apr 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Masao KakokiOliver Smithies
Sep 30, 2009·British Journal of Pharmacology·Marie-Thérèse BawolakFrançois Marceau
Feb 27, 2010·American Journal of Hypertension·Maria MarketouHaralambos Gavras
Sep 8, 2011·The Journal of Clinical Hypertension·Joseph L Izzo, Matthew R Weir
Apr 18, 2013·The Journal of Pharmacology and Experimental Therapeutics·Louis PotierNadine Bouby

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Software Mentioned

Biopac
Prism
GraphPad
Acknowledge

Related Concepts

Related Feeds

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.